Obesity and outcomes after sacrocolpopexy.
OBJECTIVE
The purpose of this study was to compare outcomes after sacrocolpopexy (SC) between obese and healthy-weight women.


METHODS
Baseline and postoperative data were analyzed from the Colpopexy And Urinary Reduction Efforts (CARE) randomized trial of SC with or without Burch colposuspension in stress continent women with stages II-IV prolapse. Outcomes and complications were compared between obese and healthy-weight women.


RESULTS
CARE participants included 74 obese (body mass index >/=30 kg/m(2)), 122 overweight (25-29.9 kg/m(2)), and 125 healthy-weight (18.5-24.9 kg/m(2)) women, and 1 underweight (< 18.5 kg/m(2)) woman. Compared to healthy-weight women, obese women were younger (59.0 +/- 9.9 vs 62.1 +/- 10.3 yrs; P = .04), more likely to have stage II prolapse (25.7% vs 11.2%; P = .01), and had longer operative times (189 +/- 52 vs 169 +/- 58 min; P = .02). Two years after surgery, stress incontinence, prolapse, symptom resolution, and satisfaction did not differ between the obese and healthy-weight groups.


CONCLUSIONS
Most outcomes and complication rates after SC are similar in obese and healthy-weight women.
Bradley
Catherine S
CS
Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Kenton
Kimberly S
KS
Richter
Holly E
HE
Gao
Xin
X
Zyczynski
Halina M
HM
Weber
Anne M
AM
Nygaard
Ingrid E
IE
D000368:Aged; D015992:Body Mass Index; D003127:Colposcopy / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009765:Obesity / Q000150:complications* / Q000175:diagnosis; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D012016:Reference Values; D018570:Risk Assessment; D012720:Severity of Illness Index; D053825:Suburethral Slings; D013526:Surgical Mesh; D013997:Time Factors; D016896:Treatment Outcome; D014550:Urinary Incontinence, Stress / Q000175:diagnosis / Q000601:surgery*; D014563:Urodynamics; D013520:Urologic Surgical Procedures / Q000009:adverse effects / Q000379:methods; D014596:Uterine Prolapse / Q000175:diagnosis / Q000601:surgery*